Aarti Drugs (AARTIDRUGS.NS) Earnings Analysis
Aarti Drugs (AARTIDRUGS.NS) next reports earnings on 2026-07-23, consensus EPS 5.4 INR. Last quarter (2026-05-15) it beat with EPS 6.05 INR vs 5 INR est (+21%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 19.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AARTIDRUGS.NS next report earnings?
| Next earnings date | 2026-07-23 |
|---|---|
| Consensus EPS estimate | 5.4 INR |
| Revenue estimate | 6.66B |
AARTIDRUGS.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | 6.05 INR | 5 INR | +21% | Beat |
| 2026-02-03 | 4.4 INR | 4.9 INR | -10.2% | Miss |
| 2025-10-22 | 4.9 INR | 4.9 INR | 0% | Beat |
| 2025-07-18 | 5.9 INR | 4.9 INR | +20.4% | Beat |
| 2025-01-29 | 4.1 INR | 3.7 INR | +10.8% | Beat |
| 2024-10-24 | 3.9 INR | 3.9 INR | 0% | Beat |
| 2024-07-26 | 3.6 INR | 4.1 INR | -12.2% | Miss |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
AARTIDRUGS.NS valuation and analyst view
| Trailing P/E | 19.16 |
|---|---|
| Trailing EPS | 21.368 INR |
| Price / book | 2.41 |
| Dividend yield | 0.49% |
| Market cap | 37.60B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Aarti Drugs (AARTIDRUGS.NS)'s next earnings date?
Aarti Drugs is next scheduled to report on 2026-07-23, with a consensus EPS estimate of 5.4 INR and revenue estimate of 6.66B.
Did AARTIDRUGS.NS beat earnings last quarter?
In its 2026-05-15 report, AARTIDRUGS.NS posted EPS of 6.05 INR versus a 5 INR estimate — a beat of 21%.
What is AARTIDRUGS.NS's earnings track record?
Over the last 7 reported quarters with consensus data, AARTIDRUGS.NS beat estimates 5 times (71%).
What is AARTIDRUGS.NS's current P/E ratio and EPS?
AARTIDRUGS.NS trades at a trailing P/E of 19.16 on trailing EPS of 21.367911601240916 INR.
What do analysts rate AARTIDRUGS.NS?
AARTIDRUGS.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.